Market overview

Benzenesulfonyl chloride (CAS 98-09-9) is made by chlorosulfonation of benzene and is the entry point to benzenesulfonamides, sulfonate esters and the plasticiser N-butylbenzenesulfonamide used in polyamides. It also feeds pharmaceutical sulfonamides, dyes and agrochemicals. Chlorosulfonic acid supply, HCl and sulfuric acid by-product handling, and effluent compliance determine which producers stay competitive, particularly in China and India.

Key figures at a glance
– At least one public market listing values benzenesulfonyl chloride at over USD 700 bn (2024), an implausible figure for a single intermediate, which illustrates how unreliable unaudited CAS-level estimates can be (WiseGuy Reports)
– End uses span sulfonamide drugs, N-butylbenzenesulfonamide (polyamide plasticiser), dyes and agrochemicals

Recent developments among key stakeholders
– Jul 2025: China’s pesticide sector is consolidating; environmental inspections are limiting production windows, smaller producers are exiting, and the collapse of mutual data acceptance is pushing Chinese firms to costlier third-country GLP labs, lengthening registrations (AgroSpectrum)
– No major company-specific announcements for this CAS were identified in public sources for 2025-2026; the report tracks producer activity through customs data, regulatory filings and supplier interviews

What this means for the market
Consolidation in Chinese fine chemicals favours larger chlorosulfonation producers with effluent treatment, which affects supply and price.

How published estimates compare
Public estimates for this CAS are not usable as they stand. Market Krystal builds the market from benzene chlorosulfonation capacity, derivative production (especially N-butylbenzenesulfonamide and sulfonamide APIs) and trade data, and presents tonnage and value with a stated confidence range.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: sulfonamides and APIs, plasticisers, dyes, agrochemicals, reagents; grade: technical, pharmaceutical; region: China, India, Europe, North America, Japan. Each segment is backed by a producer capacity table, price benchmarks for 2020-2025 by grade and region, trade-flow analysis and a supplier risk map. Companies assessed include Lanxess, Chinese chlorosulfonation producers, Indian sulfonamide intermediate makers, Tokyo Chemical Industry, Merck KGaA. The 2036-2047 outlook uses three explicit scenarios (base, constrained supply and technology transition) rather than a single extrapolated curve.

Methodology and transparency
Every third-party figure in this report is cited to its source. Market Krystal estimates are labelled as such, with the volume, price and share assumptions behind them shown in the supporting Excel model, so buyers can audit and adjust them. Where public sources conflict, the report shows the range and explains which evidence it relies on.

The purchased delivery includes the PDF report, Excel datasets and customization around the buyer’s priority region, company set, application or commercial question.

What this research answers

The study connects production routes, named suppliers, applications, regional demand, trade, pricing drivers and commercial opportunities for this CAS number. Detailed estimates and company analysis remain inside the purchased report.